The psychological impact of false positive elevations of maternal serum alpha-fetoprotein.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 2578251
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anxiety concerning fetal malformations in pregnant women exposed or not exposed to an antenatal serum alpha-fetoprotein screening program.

  1984cited by this paper
• Maternal serum alpha-fetoprotein screening in North Carolina: experience with more than twelve thousand pregnancies.

  1983cited by this paper
• Prenatal serum alpha-fetoprotein screening for neural tube defects.

  1982cited by this paper
• Prenatal Diagnosis of Open Neural Tube Defects Using the Amniotic Fluid Acetylcholinesterase Assay

  1982cited by this paper
• Screening for neural‐tube defects and maternal anxiety

  1982cited by this paper
• Is myelomeningocele a disappearing disease?

  1982cited by this paper
• Maternal serum alpha-fetoprotein screening: a report of the Forsyth County project.

  1981cited by this paper
• Prenatal Diagnosis of Neural Tube Defects: IV. MATERNAL SERUM ALPHA-FETOPROTEIN SCREENING

  1980cited by this paper
• Maternal serum AFP screening: promise not yet fulfilled.

  1979cited by this paper
• Childbirth education, maternal attitudes, and delivery.

  1975cited by this paper
• MATERNAL ATTITUDE TO PREGNANCY INSTRUMENT. A RESEARCH TEST FOR PSYCHOGENIC OBSTETRICAL COMPLICATIONS: A PRELIMINARY REPORT.

  1964cited by this paper

• Quantifying the psychological and behavioural consequences of a diagnostic label for non-cancer conditions: systematic review

  2023cites this paper
• Screening for Down syndrome

  2017cites this paper
• Perceived pain and anxiety before and after amniocentesis among pregnant Turkish women.

  2009cites this paper
• A Prospective Study on the Effect of Rapid Aneuploidy Testing (Amnio-PCR) on Anxiety Levels and Quality of Life Measures in Women and Their Partners with Positive Down Screening Result

  2008cites this paper
• Indeterminate HIV-1 western blots

  2007cites this paper
• PHYSICAL, PSYCHOLOGICAL AND SOCIAL HARM

  2006cites this paper
• Does prenatal screening influence anxiety levels of pregnant women? A longitudinal randomised controlled trial

  2006influential citation
• 'Just a bystander'? Men's place in the process of fetal screening and diagnosis.

  2006cites this paper
• Distress Associated with Prenatal Screening for Fetal Abnormality

  2005cites this paper
• Use of prenatal screening tests in Finland

  2005cites this paper
• Dysthymic Reactions of Women Undergoing Chorionic Villus Sampling for Prenatal Diagnosis of Hemoglobinopathies or Karyotyping

  2004cites this paper
• How do women of diverse backgrounds value prenatal testing outcomes?

  2004cites this paper
• Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review.

  2004cites this paper
• Antenatal Diagnosis of Surgically Correctable Anomalies: Effects of Repeated Consultations on Parental Anxiety

  2003cites this paper
• The effect of fast reporting by amnio‐PCR on anxiety levels in women with positive biochemical screening for Down syndrome — a randomized controlled trial

  2002cites this paper
• Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy

  2002cites this paper
• The routinization of prenatal testing.

  2002cites this paper
• Triple-marker screening in British Columbia: current practice and future options.

  2001cites this paper
• Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.

  2001cites this paper
• Strategies for motivating Latino couples' participation in qualitative health research and their effects on sample construction.

  2001cites this paper
• Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.

  2000cites this paper
• Latinas, Amniocentesis and the Discourse of Choice

  2000cites this paper
• Participation in maternal serum screening following screen positive results in a previous pregnancy

  2000cites this paper
• Male Partners' Role in Latinas' Amniocentesis Decisions

  1999cites this paper
• Ethnicity, bioethics, and prenatal diagnosis: the amniocentesis decisions of Mexican-origin women and their partners.

  1999cites this paper
• 'Because of the risks': how US pregnant women account for refusing prenatal screening.

  1999cites this paper
• On what grounds do women participate in prenatal screening?

  1998cites this paper
• Coping with serum screening for Down syndrome when the result is given as a numeric value

  1998cites this paper
• Can Decision Analysis Help Us Decide Whether Ultrasound Screening for Fetal Anomalies Is Worth It?

  1998cites this paper
• Women's decision-making in prenatal screening.

  1998cites this paper
• Why women say yes to prenatal diagnosis.

  1997cites this paper
• Assessment of maternal anxiety following neonatal screening and investigation for occult spinal dysraphism

  1997cites this paper
• Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm.

  1996cites this paper
• Women's experiences of prenatal serum screening.

  1996cites this paper
• Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits

  1996cites this paper
• Pre-screening education in multiple marker screening programs: The effect on patient anxiety and knowledge

  1996cites this paper
• Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.

  1996cites this paper
• Risk communication; the patient's view.

  1996cites this paper
• Couples' Evaluations of Foreknowledge of Fetal Impairment

  1996cites this paper
• Attitudes toward maternal serum screening in Chinese women with positive results

  1996cites this paper
• User acceptability of an alpha-fetoprotein screening programme.

  1995cites this paper
• Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.

  1994cites this paper
• The psychological effects of counting fetal movements.

  1994cites this paper
• Alpha-fetoprotein screening programs: what every obstetric sonologist should know.

  1993cites this paper
• Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.

  1993cites this paper
• Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial.

  1993cites this paper
• Psychological impact of screening for familial ovarian cancer.

  1993cites this paper
• Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.

  1993cites this paper
• Maternal serum alpha-fetoprotein testing: physician experience and attitudes and their influence on patient acceptance.

  1992cites this paper
• Current issues in maternal serum alpha-fetoprotein screening.

  1992cites this paper
• The psychological costs of screening for cancer.

  1992cites this paper
• Indeterminate HIV-1 western blots

  1992cites this paper
• The psychological effects of false‐positive results in prenatal screening for fetal abnormality: A prospective study

  1992cites this paper
• Psychosocial issues in implementing mammography screening in Australia

  1992cites this paper
• Prenatal screening for neural tube defects: perceptions of potential recipients.

  1991cites this paper
• Patient Attitudes Toward Testing for Maternal Serum Alpha-Fetoprotein Values When Results Are False-Positive or True-Negative

  1991cites this paper
• Anxiety in women with low maternal serum alpha‐fetoprotein screening results

  1991cites this paper
• Amniocentesis in the context of infertility.

  1991cites this paper
• Research studies in applied human genetics: a quantitative analysis and critical review of recent literature.

  1991cites this paper
• Patterns of mood states in pregnant women undergoing chorionic villus sampling or amniocentesis.

  1990cites this paper
• Social and ethical problems of fetal diagnosis and screening.

  1989cites this paper
• Maternal serum alpha-fetoprotein screening.

  1989cites this paper
• Factors affecting the uptake of screening for neural tube defect

  1988cites this paper
• Should maternal alpha-fetoprotein estimation be carried out in centers where ultrasound screening is routine? A sensitivity analysis approach.

  1988cites this paper
• Consumer-oriented studies in relation to prenatal screening tests.

  1988cites this paper
• Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up.

  1988cites this paper
• Psychological Problems in Relation to Neonatal Screening Programmes

  1988cites this paper
• Determinants of altered anxiety after abnormal maternal serum alpha-fetoprotein screening.

  1988cites this paper
• Neural tube defects: epidemiology, detection, and prevention.

  1987cites this paper
• Psychological impact of amniocentesis on low‐risk women

  1987cites this paper
• Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.

  1987cites this paper
• Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.

  1986cites this paper
• Psychological response to amniocentesis: I. Mood state and adaptation to pregnancy.

  1986cites this paper
• The characteristics of a population of Canadian women offered maternal serum alphafetoprotein screening during pregnancy.

  1986cites this paper
• Maternal serum alpha-fetoprotein screening: the effect of participation on anxiety and attitude toward pregnancy in women with normal results.

  1985cites this paper
• Screening for Neural Tube Defects — Including Folic Acid / Folate Prophylaxis

  year unknowncites this paper